Theodorakopoulos Theodoros, Kalafateli Maria, Kalambokis Georgios N, Samonakis Dimitrios N, Aggeletopoulou Ioanna, Tsolias Chrysostomos, Mantaka Aikaterini, Tselekouni Paraskevi, Vourli Georgia, Assimakopoulos Stelios F, Gogos Charalampos, Thomopoulos Konstantinos, Milionis Haralampos, Triantos Christos
Division of Gastroenterology, Department of Internal Medicine, University Hospital of Patras (Theodoros Theodorakopoulos, Maria Kalafateli, Ioanna Aggeletopoulou, Chrysostomos Tsolias, Paraskevi Tselekouni, Konstantinos Thomopoulos, Christos Triantos).
Division of Internal Medicine, First Division of Internal Medicine and Liver Unit, Medical School, University of Ioannina, Ioannina (Georgios N. Kalambokis, Haralampos Milionis).
Ann Gastroenterol. 2021;34(1):93-103. doi: 10.20524/aog.2020.0553. Epub 2020 Nov 20.
No evidence is available on the natural history of grade 1 ascites and its progression to grade 2/3 in patients with liver cirrhosis. The aim of the current study was to address this issue, to assess the development of main comorbid disorders closely related to ascites progression, and to identify the predictive factors for survival in this setting.
Consecutive Caucasian cirrhotic patients with grade 1 ascites were retrospectively analyzed. None of patients was under treatment with diuretics at diagnosis. Control groups consisted of 145 cirrhotics with grade 2/3 ascites and 175 cirrhotics without ascites.
Diuretics were initiated in 58 patients with grade 1 ascites at baseline by the attending physician. At the last follow up, 29 patients had no ascites, 33 patients had grade 1 and 38 patients had grade 2/3 ascites. No variable was found to be an independent predictor of grade 2/3 ascites. Seven patients developed spontaneous bacterial peritonitis while under treatment with diuretics; at that time only 1 patient had grade 1 ascites. The mortality rate was similar among all examined groups.
This study suggests that the presence of grade 1 ascites does not constitute a precursor of grade 2/3 ascites in patients with cirrhosis. Thus, patients with grade 1 ascites do not require specific treatment with diuretics.
目前尚无关于肝硬化患者1级腹水的自然病程及其进展为2/3级腹水的证据。本研究的目的是解决这一问题,评估与腹水进展密切相关的主要合并症的发生情况,并确定该情况下生存的预测因素。
对连续性的白种人1级腹水肝硬化患者进行回顾性分析。诊断时所有患者均未接受利尿剂治疗。对照组包括145例2/3级腹水的肝硬化患者和175例无腹水的肝硬化患者。
在基线时,主治医师对58例1级腹水患者开始使用利尿剂。在最后一次随访时,29例患者无腹水,33例患者为1级腹水,38例患者为2/3级腹水。未发现任何变量是2/3级腹水的独立预测因素。7例患者在接受利尿剂治疗时发生自发性细菌性腹膜炎;当时只有1例患者为1级腹水。所有检查组的死亡率相似。
本研究表明,1级腹水的存在并不构成肝硬化患者2/3级腹水的先兆。因此,1级腹水患者不需要使用利尿剂进行特殊治疗。